Stone, Richard A. https://orcid.org/0000-0002-9833-4425
Tobias, John W. https://orcid.org/0000-0002-5362-7013
Wei, Wenjie https://orcid.org/0000-0002-1720-1808
Schug, Jonathan https://orcid.org/0000-0001-6885-7869
Wang, Xia https://orcid.org/0009-0005-5336-7011
Zhang, Lixin https://orcid.org/0009-0003-7779-0733
Iuvone, P. Michael https://orcid.org/0000-0002-2510-3896
Nickla, Debora L. https://orcid.org/0000-0003-4027-8237
Funding for this research was provided by:
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
National Institutes of Health (R01 EY025307)
Research to Prevent Blindness (Challenge Grant to Emory Eye Center)
Paul and Evanina Bell Mackall Foundation Trust
Article History
Received: 10 May 2023
Accepted: 22 December 2023
First Online: 4 January 2024
Competing interests
: R.A.S. serves as an advisor to IVIEW Therapeutics, Inc. All other authors declare no competing interest.